****** Drug Delivery Devices Market Opportunities and Forecast 2020-30

Bharat Book Bureau Provides the Trending Market Research Report on “Drug Delivery Devices ****** Market Report 2020-30under Life Sciences Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

Drug Delivery Devices Market ****** Report 2020: Covid 19 Implications and Growth from The Business Research Company covers this critical market and the impact on it from the Covid 19 virus.

It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for drug delivery devices which play a critical role in the treatment of patients with Covid 19.

Request a free sample copy of Drug Delivery Devices Market Report @


Bharat Book Logo Jpg

Reasons to Purchase
• Gain a truly ****** perspective with the most comprehensive report available on this market covering 20+ geographies.
• Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the drug delivery devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Drug Delivery Devices market ****** report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider drug delivery devices market, and compares it with other markets.
• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
• Market segmentations break down market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
• Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
• The drug delivery devices market section of the report gives context. It compares the drug delivery devices market with other segments of the drug delivery devices market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, drug delivery devices indicators comparison.


Markets Covered: 1) By Route Of Administration: Oral Drug Delivery; Injectable Drug Delivery; Topical Drug Delivery; Ocular Drug Delivery; Pulmonary Drug Delivery; Nasal Drug Delivery; Transmucosal Drug Delivery; Implantable Drug Delivery; 2) By Patient Care Setting: Hospitals; Diagnostic Centers; Ambulatory Surgery Centers/Clinics; Home Care Settings; Others; 3) By Application: Cancer; Infectious Diseases; Respiratory Diseases; Diabetes; Cardiovascular Diseases; Autoimmune Diseases; Central Nervous System Disorders; Others

Companies Mentioned: F. Hoffmann-La Roche Ltd; 3M Company; Pfizer Inc.; Baxter International

Countries: Brazil; China; France; Germany; India; Indonesia; Japan; South Korea; Russia; UK; USA and Australia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Major players in the drug delivery devices market are F. Hoffmann-La Roche Ltd, 3M Company, Pfizer Inc., Baxter International, BD., Novartis AG, Gerresheimer AG, Johnson & Johnson Services, Inc., Bayer AG, and GlaxoSmithKline plc.

The ****** drug delivery devices market is expected to grow from $1.4 billion in 2019 to about $1.6 billion in 2020 as there is a marginal increase in demand due to the use of such devices in the treatment of Covid-19 patients. The market is expected to stabilize and reach $1.9 billion at a CAGR of 8.2% through 2023.

Drug delivery devices, specifically respiratory-based delivery devices, are estimated to gain demand owing to the Covid-19 pandemic. Drugs used for Covid-19 treatment are both oral and injectable; however, a marginal increase is expected for pulmonary or respiratory-based drug delivery devices.

The drug delivery devices market consists of the sales of medical devices and equipment that are used for delivering specific drugs to a specific part of the body to cure chronic diseases such as cancer, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases. The market includes the sales of the devices that are specifically made for delivering the specific drugs according to the various administration techniques such as oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery and implantable drug delivery. Drug delivery devices used in various patient care settings such as hospitals, diagnostic centers, pharmaceutical companies, clinics and home care settings are included in this market.

The drug delivery devices market in Asia Pacific is forecasted to register the highest CAGR during 2019-2023.

The regulatory changes related to medical devices is expected to restraint the growth of drug delivery devices market. The companies operating in the market are required to adapt according to the changes in the regulatory framework, which may limit business at the bottom line. Also, companies will have to bear the heavy cost of adapting to the changing regulatory framework. Also, the sudden changes in the regulatory framework related to medical devices can result in losses, fines, penalties at a ****** level. For instance, European Union (EU) and the parliament in 2017 approved the new Medical Device Regulation (MDR) and Medical Device Single Audit Program (MDSAP) to monitor all the medical devices for quality. The new MDSAP will come into effect from 2020 and is adopted by regulators in the US, Canada, Japan, Brazil, and Australia. Following the changes, in Canada, all the medical device manufacturers including drug delivery products manufacturers, will have to comply with the requirements of MDSAP and are required to submit the MDSAP reports to the regulatory body in order to obtain or maintain the device licenses, resulting in high costs and time loss. Thus, the growth of the drug delivery devices market is limited by the regulatory changes related to medical devices.

The microneedle (MN), is a highly efficient and versatile medical device technology, due to its prominent properties including painless penetration, low cost, excellent therapeutic efficacy, and relative safety. The major players operating in the ****** microneedle drug delivery system include, 3M, Vetter Pharma International GmbH, nanoBioSciences LLC, NanoPass and more. The microneedles are fabricated using biodegradable polymers in which drugs or vaccines are encapsulated in the microneedles. Once, the microneedles dissolve in the skin, the drug gets released. This novel delivery method allows a wider variety of molecules to pass the skin’s barrier, thus allowing the transdermal delivery to be applied to a large range of clinical applications, including diabetes, severe osteoporosis, and influenza vaccination.

The rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer and other diseases is expected to drive the drug delivery devices market. According to the world health organization (WHO), by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide, and that 71% of deaths due to ischemic heart disease (IHD), 75% of deaths due to stroke, and 70% of deaths due to diabetes will occur in developing countries. There are various routes of drug administration for medical drugs. The selection of the route depends on three factors – the effect desired; the type of the disease and the type of the product. Currently, the development of new drug delivery systems plays a major role in pharmaceutical industries. Research and development (R&D) in drug delivery is increasing throughout the world due to increasing prevalence of these diseases. Most of the pharmaceutical companies are focusing on multiple drug delivery technologies for creating excellent advantages and better outcome for their marketed products. Hence, the increasing prevalence of chronic diseases is resulting in increased consumption of therapeutic drugs and therapies, and this factor is expected to act as a driver for the growth of the drug delivery devices market.

In September 2018, Sulzer Ltd., a Swiss-based industrial engineering company specialized in pumping, agitation, mixing, separation and application technologies for all fluid types, acquired Medmix Systems AG for an undisclosed amount. Through this acquisition, Sulzer Ltd. aims towards broadening its business segment in the healthcare division by utilizing the product portfolio offered by Medmix System. Medmix Systems AG is a Switzerland-based manufacturer of medical equipment & devices, that specializes in providing applicators for drug delivery, bone repair, oral surgery in the healthcare industry.

Companies in the drug delivery devices market are collaborating with other companies within the industry in order to strengthen their product portfolio as well as to expand their footprint across different geographies. For instance, in July 2018, Gerresheimer AG, a Germany based provider of pharmaceutical packaging and drug delivery devices, acquired Sensile Medical AG for $413.4 million. The acquisition helped Gerresheimer AG in broadening its technological portfolio by enabling them to offer drug delivery devices for pharmaceutical and biopharmaceutical customers. Sensile Medical AG is a Switzerland based manufacturer of liquid drug delivery devices.

Browse our full report with Table of Content :


About Bharat Book Bureau:

Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:

Bharat Book Bureau

Tel: +91 22 27810772 / 27810773

Email: poonam@bharatbook.com

Website: www.bharatbook.com

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.